These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23594703)

  • 1. The TNF-α/sphingosine-1-phosphate signaling axis drives myogenic responsiveness in heart failure.
    Kroetsch JT; Bolz SS
    J Vasc Res; 2013; 50(3):177-85. PubMed ID: 23594703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proximal cerebral arteries develop myogenic responsiveness in heart failure via tumor necrosis factor-α-dependent activation of sphingosine-1-phosphate signaling.
    Yang J; Noyan-Ashraf MH; Meissner A; Voigtlaender-Bolz J; Kroetsch JT; Foltz W; Jaffray D; Kapoor A; Momen A; Heximer SP; Zhang H; van Eede M; Henkelman RM; Matthews SG; Lidington D; Husain M; Bolz SS
    Circulation; 2012 Jul; 126(2):196-206. PubMed ID: 22668972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor-α-mediated downregulation of the cystic fibrosis transmembrane conductance regulator drives pathological sphingosine-1-phosphate signaling in a mouse model of heart failure.
    Meissner A; Yang J; Kroetsch JT; Sauvé M; Dax H; Momen A; Noyan-Ashraf MH; Heximer S; Husain M; Lidington D; Bolz SS
    Circulation; 2012 Jun; 125(22):2739-50. PubMed ID: 22534621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Necrosis Factor/Sphingosine-1-Phosphate Signaling Augments Resistance Artery Myogenic Tone in Diabetes.
    Sauvé M; Hui SK; Dinh DD; Foltz WD; Momen A; Nedospasov SA; Offermanns S; Husain M; Kroetsch JT; Lidington D; Bolz SS
    Diabetes; 2016 Jul; 65(7):1916-28. PubMed ID: 27207546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingosine-1-phosphate-dependent activation of p38 MAPK maintains elevated peripheral resistance in heart failure through increased myogenic vasoconstriction.
    Hoefer J; Azam MA; Kroetsch JT; Leong-Poi H; Momen MA; Voigtlaender-Bolz J; Scherer EQ; Meissner A; Bolz SS; Husain M
    Circ Res; 2010 Oct; 107(7):923-33. PubMed ID: 20671234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutically Targeting Tumor Necrosis Factor-α/Sphingosine-1-Phosphate Signaling Corrects Myogenic Reactivity in Subarachnoid Hemorrhage.
    Yagi K; Lidington D; Wan H; Fares JC; Meissner A; Sumiyoshi M; Ai J; Foltz WD; Nedospasov SA; Offermanns S; Nagahiro S; Macdonald RL; Bolz SS
    Stroke; 2015 Aug; 46(8):2260-70. PubMed ID: 26138121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor-α enhances microvascular tone and reduces blood flow in the cochlea via enhanced sphingosine-1-phosphate signaling.
    Scherer EQ; Yang J; Canis M; Reimann K; Ivanov K; Diehl CD; Backx PH; Wier WG; Strieth S; Wangemann P; Voigtlaender-Bolz J; Lidington D; Bolz SS
    Stroke; 2010 Nov; 41(11):2618-24. PubMed ID: 20930159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capitalizing on diversity: an integrative approach towards the multiplicity of cellular mechanisms underlying myogenic responsiveness.
    Lidington D; Schubert R; Bolz SS
    Cardiovasc Res; 2013 Mar; 97(3):404-12. PubMed ID: 23180720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Effects of Long Term FTY720 Treatment on Endothelial versus Smooth Muscle Cell Signaling to S1P in Rat Mesenteric Arteries.
    Hamidi Shishavan M; Bidadkosh A; Yazdani S; Lambooy S; van den Born J; Buikema H; Henning RH; Deelman LE
    PLoS One; 2016; 11(9):e0162029. PubMed ID: 27583547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosine-1-phosphate in the regulation of vascular tone: a finely tuned integration system of S1P sources, receptors, and vascular responsiveness.
    Levkau B
    Circ Res; 2008 Aug; 103(3):231-3. PubMed ID: 18669929
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of sphingosine kinase 1/sphingosine-1-phosphate pathway in the myogenic tone of posterior cerebral arteries.
    Lim M; Choi SK; Cho YE; Yeon SI; Kim EC; Ahn DS; Lee YH
    PLoS One; 2012; 7(4):e35177. PubMed ID: 22532844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingosine-1-Phosphate Signaling Regulates Myogenic Responsiveness in Human Resistance Arteries.
    Hui S; Levy AS; Slack DL; Burnstein MJ; Errett L; Bonneau D; Latter D; Rotstein OD; Bolz SS; Lidington D; Voigtlaender-Bolz J
    PLoS One; 2015; 10(9):e0138142. PubMed ID: 26367262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independence of tumor necrosis factor-alpha-induced adhesion molecule expression from sphingosine 1-phosphate signaling in vascular endothelial cells.
    Miura Y; Yatomi Y; Ohmori T; Osada M; Ozaki Y
    J Thromb Haemost; 2004 Jun; 2(6):1019-21. PubMed ID: 15140149
    [No Abstract]   [Full Text] [Related]  

  • 14. Sphingosine 1-phosphate as a therapeutic target in heart failure: more questions than answers.
    Mann DL
    Circulation; 2012 Jun; 125(22):2692-4. PubMed ID: 22534620
    [No Abstract]   [Full Text] [Related]  

  • 15. HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects.
    Argraves KM; Argraves WS
    J Lipid Res; 2007 Nov; 48(11):2325-33. PubMed ID: 17698855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine-1-phosphate and modulation of vascular tone.
    Igarashi J; Michel T
    Cardiovasc Res; 2009 May; 82(2):212-20. PubMed ID: 19233865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive smooth muscle tumour necrosis factor regulates microvascular myogenic responsiveness and systemic blood pressure.
    Kroetsch JT; Levy AS; Zhang H; Aschar-Sobbi R; Lidington D; Offermanns S; Nedospasov SA; Backx PH; Heximer SP; Bolz SS
    Nat Commun; 2017 Apr; 8():14805. PubMed ID: 28378814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosine-1-Phosphate Signaling in Endothelial Disorders.
    Sanchez T
    Curr Atheroscler Rep; 2016 Jun; 18(6):31. PubMed ID: 27115142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming Growth Factor
    Ji Y; Lisabeth EM; Neubig RR
    Mol Pharmacol; 2021 Aug; 100(2):53-60. PubMed ID: 34031187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CFTR Therapeutics Normalize Cerebral Perfusion Deficits in Mouse Models of Heart Failure and Subarachnoid Hemorrhage.
    Lidington D; Fares JC; Uhl FE; Dinh DD; Kroetsch JT; Sauvé M; Malik FA; Matthes F; Vanherle L; Adel A; Momen A; Zhang H; Aschar-Sobbi R; Foltz WD; Wan H; Sumiyoshi M; Macdonald RL; Husain M; Backx PH; Heximer SP; Meissner A; Bolz SS
    JACC Basic Transl Sci; 2019 Dec; 4(8):940-958. PubMed ID: 31909302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.